Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03543098Not ApplicableActive Not Recruiting

STaR Trial: Multiple Ligament Knee Injuries

Role: collaborator

NCT03804853Not ApplicableRecruiting

Rehabilitation Following Reverse Total Shoulder Arthroplasty

Role: collaborator

NCT00225095Phase 1Completed

A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

Role: collaborator

NCT03248011Not ApplicableCompleted

Hamstring Strain in High School Athletes

Role: collaborator

All 4 trials loaded